Cargando…
Deficits in plasma oestradiol measurement in studies and management of breast cancer
The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in p...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064106/ https://www.ncbi.nlm.nih.gov/pubmed/15642174 http://dx.doi.org/10.1186/bcr960 |
_version_ | 1782123291762229248 |
---|---|
author | Dowsett, Mitch Folkerd, Elizabeth |
author_facet | Dowsett, Mitch Folkerd, Elizabeth |
author_sort | Dowsett, Mitch |
collection | PubMed |
description | The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in premenopausal women. The application of these methodologies to the quantification of the very low levels of oestradiol in postmenopausal women is more problematic in terms of accuracy and interpretation. The importance of using appropriate methodology is discussed and illustrated with data demonstrating the disparity in the results obtained when low levels of oestradiol were quantified using direct and indirect methods. |
format | Text |
id | pubmed-1064106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-10641062005-03-11 Deficits in plasma oestradiol measurement in studies and management of breast cancer Dowsett, Mitch Folkerd, Elizabeth Breast Cancer Res Commentary The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in premenopausal women. The application of these methodologies to the quantification of the very low levels of oestradiol in postmenopausal women is more problematic in terms of accuracy and interpretation. The importance of using appropriate methodology is discussed and illustrated with data demonstrating the disparity in the results obtained when low levels of oestradiol were quantified using direct and indirect methods. BioMed Central 2005 2004-10-28 /pmc/articles/PMC1064106/ /pubmed/15642174 http://dx.doi.org/10.1186/bcr960 Text en Copyright © 2004 BioMed Central Ltd |
spellingShingle | Commentary Dowsett, Mitch Folkerd, Elizabeth Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title | Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title_full | Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title_fullStr | Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title_full_unstemmed | Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title_short | Deficits in plasma oestradiol measurement in studies and management of breast cancer |
title_sort | deficits in plasma oestradiol measurement in studies and management of breast cancer |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064106/ https://www.ncbi.nlm.nih.gov/pubmed/15642174 http://dx.doi.org/10.1186/bcr960 |
work_keys_str_mv | AT dowsettmitch deficitsinplasmaoestradiolmeasurementinstudiesandmanagementofbreastcancer AT folkerdelizabeth deficitsinplasmaoestradiolmeasurementinstudiesandmanagementofbreastcancer |